-
Fake breast cancer drug on market causes alarm
13 May 2024 03:35 GMT
… is a drug that has been approved for the treatment of early … medroxyprogesterone injections.
Others include analgesics, antipsychotics, medicines used in maternal, … hospitals, health centres, dispensaries and pharmaceutical outlets.
“Samples collected will …
-
Manish Jha, MD: Treatment Options for Treatment-Resistant Depression
10 May 2024 19:03 GMT
… management. The first antipsychotic medication approved for treatment-resistant depression was olanzapine … fluoxetine. Second-generation antipsychotics are approved for the treatment as an augmentation …
-
Antipsychotic Use and Psychiatric Hospitalization in First-Episode Psychosis and Cannabis Use Disorder
10 May 2024 18:04 GMT
… dispensed antipsychotics and other psychotropics were acquired from the Prescribed Drug Register. Antipsychotic … entry, and temporal order of antipsychotic treatments). Traditional multivariable between-person Cox …
-
Fierce Pharma Asia—Takeda restructures; Lilly, Innovent tout GLP-1 win; BIO warns of decoupling damage
10 May 2024 19:02 GMT
… culls cancer, gut and inflammation drugs in R&D rethink … its bottom line. The Japanese pharma will “reduce layers” and “ … April's largest TV drug ad spender as Otsuka, Lundbeck … .2 million for the atypical antipsychotic. AbbVie, which has consistently …
-
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript
10 May 2024 19:03 GMT
… by. Welcome to Royalty Pharma First Quarter 2024 Earnings … 48 weeks. Importantly, the treatment was well tolerated with … peak royalty to Royalty Pharma, with frexalimab and olpasiran … injectable version of the antipsychotic olanzapine, achieved its primary …
-
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
09 May 2024 19:55 GMT
… Welcome to the ACADIA Pharmaceuticals First Quarter 2024 Financial … prior quarter, while other antipsychotics and NUPLAZID both increased … a new drug application for the treatment of Hyperphagia … ;A Session Follow Acadia Pharmaceuticals Inc (NASDAQ:ACAD) …
-
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
09 May 2024 16:47 GMT
… some currently marketed branded antipsychotics for which physical … approved long-acting injectable treatment. In addition to … currently approved drugs in this atypical antipsychotic class have … stocking at certain specialty pharmacy customers. HETLIOZ net …
-
Teva, Medincell's schizophrenia drug succeeds in late-stage study
09 May 2024 05:17 GMT
… Pharmaceuticals and French partner Medincell said on Wednesday their experimental schizophrenia drug … the drug - an under-the-skin version of a generic antipsychotic … administered into a muscle.
Other treatments for the disease include Vanda …
-
3 Barriers to Improving Clozapine Use in Treatment-Resistant Schizophrenia
08 May 2024 21:48 GMT
… an antipsychotic indicated for the treatment of adults with treatment-resistant schizophrenia … . Clozapine and Second-Generation Antipsychotics for Schizophrenia, with John … -generation-antipsychotics-schizophrenia-john-kane
US Food & Drug Administration. …
-
Long-Acting Injectable vs Oral Antipsychotics: Part 2 of a Conversation With Peter J. Weiden, MD
08 May 2024 19:00 GMT
CONFERENCE REPORTER
Psychiatric Times Editor-in-Chief, John J. Miller, MD, sat down with his colleague, Peter J. Weiden, MD, of the State University of New York at Stony Brook at the 2024 American Psychiatric Association (APA) Annual Meeting. In part 2 of …